SCHEMBL27285205

SCHEMBL27285205

CC(C)(C)OC(=O)[C@H](Cc1cc(Cl)ccc1-c1ccccn1)N=C(c1ccccc1)c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AAK1 Q2M2I8 1/20 0.49
PPARG P37231 1/20 0.36
PPARD Q03181 1/20 0.36
PPARA Q07869 1/20 0.36
GRM5 P41594 2/20 0.35
CNR1 P21554 1/20 0.35
CNR2 P34972 1/20 0.35
SHMT1 P34896 1/20 0.34
MGLL Q99685 1/20 0.34
KDM4E B2RXH2 2/20 0.34
CYP3A4 P08684 1/20 0.34
SCN9A Q15858 1/20 0.34
MAPT P10636 2/20 0.33
NPSR1 Q6W5P4 2/20 0.33
CTSL P07711 1/20 0.33
MAPK1 P28482 1/20 0.33
PTGER1 P34995 2/20 0.33
CYP2C9 P11712 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27285202 0.82 AAK1 (0.55) AAK1PPARGPPARAKDM4EMAPT
SCHEMBL31276231 0.81 AAK1 (0.53) AAK1CNR1CNR2KDM4EMAPT
SCHEMBL31276539 0.80 AAK1 (0.52) AAK1PPARGPPARACNR1CNR2
SCHEMBL25270127 0.78 AAK1 (0.52) AAK1CNR1CNR2MAPTCTSL
SCHEMBL5981702 0.77 AAK1 (0.61) AAK1PPARGPPARACNR1CNR2
SCHEMBL5981707 0.77 AAK1 (0.61) AAK1PPARGPPARACNR1CNR2
SCHEMBL25318293 0.77 AAK1 (0.61) AAK1PPARGPPARACNR1MAPT
SCHEMBL30461888 0.77 AAK1 (0.56) AAK1CNR1CNR2KDM4EMAPT
SCHEMBL25267930 0.77 AAK1 (0.56) AAK1CNR1CNR2KDM4EMAPT
SCHEMBL18103805 0.77 AAK1 (0.56) AAK1MAPTNPSR1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240218021-A1 CYCLIN INHIBITORS CIRCLE PHARMA, INC. 2024-07-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240218021-A1 CYCLIN INHIBITORS CCNI, CCNC, CDK2 AAK1 1228/4885PPARG 1553/4885PPARD 2693/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.